Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus

• Main Authors: Hector E. Sanchez-Ibarra (Author), Luisa M. Reyes-Cortes (Author), Xian-Li Jiang (Author), Claudia M. Luna-Aguirre (Author), Dionicio Aguirre-Trevino (Author), Ivan A. Morales-Alvarado (Author), Rafael B. Leon-Cachon (Author), Fernando Lavalle-Gonzalez (Author), Faruck Morcos (Author), Hugo A. Barrera-Saldaña (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The treatment of Type 2 Diabetes Mellitus (T2DM) consists primarily of oral antidiabetic drugs (OADs) that stimulate insulin secretion, such as sulfonylureas (SUs) and reduce hepatic glucose production (e.g., biguanides), among others. The marked inter-individual differences among T2DM patients'...